Pharming Group N.V. (AMS:PHARM)
Netherlands · Delayed Price · Currency is EUR 1.171
-0.015 (-1.26%)
May 27, 2026, 2:30 PM CET
Pharming Group Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 12.36 | 2.85 | -11.84 | -10.55 | 13.67 | 16 |
Depreciation & Amortization | 10.86 | 10.32 | 10.19 | 10.13 | 9.33 | 9.17 |
Other Amortization | 0.89 | 0.89 | 0.85 | 0.88 | - | - |
Loss (Gain) From Sale of Assets | - | - | - | -21.28 | - | - |
Asset Writedown & Restructuring Costs | - | - | 5.03 | 4.92 | 3.86 | 10.44 |
Loss (Gain) From Sale of Investments | -2.35 | -2.35 | -4.99 | 0.93 | -11.06 | -0.11 |
Loss (Gain) on Equity Investments | -0.47 | -0.62 | 1.76 | 0.29 | 1.08 | -0.69 |
Stock-Based Compensation | 14.42 | 13.77 | 11.25 | 9.25 | 6.39 | 9.06 |
Other Operating Activities | 11.31 | 19.46 | -3.97 | 5.09 | -0.44 | -1.05 |
Change in Accounts Receivable | -13.14 | -3.36 | -6.78 | -18.54 | 2.36 | 5.92 |
Change in Inventory | -0.47 | -1.29 | -0.5 | -14.43 | -15.02 | -6.15 |
Change in Accounts Payable | 22.27 | 14.13 | -2.77 | 16.23 | 11.99 | -5.19 |
Change in Other Net Operating Assets | 0.75 | 0.9 | -0.02 | -0.22 | 0.27 | 0.47 |
Operating Cash Flow | 56.43 | 54.71 | -1.8 | -17.3 | 22.46 | 37.84 |
Operating Cash Flow Growth | 827.48% | - | - | - | -40.65% | -54.75% |
Capital Expenditures | -0.71 | -0.75 | -0.79 | -1.44 | -1.38 | -10.74 |
Cash Acquisitions | - | -57.48 | - | - | - | - |
Sale (Purchase) of Intangibles | - | -0.01 | -0.01 | 21.25 | -0.6 | -5.98 |
Investment in Securities | -67.49 | 84.48 | 32.41 | -149.2 | 7.3 | -4.59 |
Other Investing Activities | -0 | -0 | - | - | - | - |
Investing Cash Flow | -68.2 | 26.25 | 31.62 | -129.39 | 5.32 | -21.31 |
Long-Term Debt Issued | - | - | 104.54 | - | - | - |
Long-Term Debt Repaid | - | -4.25 | -138.93 | -4.04 | -3.31 | -3.22 |
Net Debt Issued (Repaid) | -16.51 | -4.25 | -34.39 | -4.04 | -3.31 | -3.22 |
Issuance of Common Stock | 23.45 | 19.81 | 5.58 | 8.13 | 2.28 | 4.72 |
Other Financing Activities | -7.95 | -14.07 | -5.6 | -5.13 | -3.95 | -29.45 |
Financing Cash Flow | -1.01 | 1.5 | -34.41 | -1.04 | -4.98 | -27.95 |
Foreign Exchange Rate Adjustments | 5.07 | 7.91 | -2.21 | 2.13 | -7.38 | -1.83 |
Miscellaneous Cash Flow Adjustments | -0 | -0 | - | - | - | - |
Net Cash Flow | -7.71 | 90.36 | -6.8 | -145.6 | 15.42 | -13.24 |
Free Cash Flow | 55.72 | 53.96 | -2.59 | -18.74 | 21.08 | 27.1 |
Free Cash Flow Growth | 994.32% | - | - | - | -22.21% | -65.68% |
Free Cash Flow Margin | 15.08% | 14.35% | -0.87% | -7.64% | 10.25% | 13.63% |
Free Cash Flow Per Share | 0.07 | 0.07 | -0.00 | -0.03 | 0.03 | 0.04 |
Cash Interest Paid | 6.05 | 6.2 | 5.6 | 5.13 | 3.95 | 4.45 |
Cash Income Tax Paid | 4.93 | 4.6 | 15.58 | 0.66 | 1.24 | - |
Levered Free Cash Flow | 59.02 | 68.65 | 0.24 | 8.06 | 16.23 | -17.14 |
Unlevered Free Cash Flow | 64.22 | 75.35 | 5.7 | 11.78 | 19.58 | -13.33 |
Change in Working Capital | 9.41 | 10.39 | -10.07 | -16.96 | -0.39 | -4.96 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.